missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Phosphotyrosine Monoclonal Antibody (pY20), HRP

Mouse Monoclonal Antibody
Marque: Invitrogen™ MA112445
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
A suggested positive control for this product is A431 cells stimulated with EGF.
The role of tyrosine phosphorylation in transduction of the mitogenic signal from transmembrane receptors and in transformation by oncogene tyrosine kinases has been the subject of intense investigation for several years. While the phosphorylation of specific tyrosine residues has been shown to be a primary mechanism of signal transduction during normal mitogenesis, cell cycle progression and oncogenic transformation, its role in other areas such as differentiation and gap junction communication, is a matter of active and ongoing research. Antibodies that specifically recognize phosphorylated tyrosine residues have proved to be invaluable to the study of tyrosine -phosphorylated proteins and the biochemical pathways in which they function. The fluorescein (FITC) conjugate of clone PY20 anti-phosphotyrosine is especially useful for the detection of these P-Tyr proteins in immunohistochemical and immunocytochemical protocols in situations wherein the use of a secondary antibody would complicate detection of the protein(s) of interest.
Spécification
| Phosphotyrosine | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 60% glycerol and 0.1% chloroacetamide | |
| Mouse | |
| Protein A/G | |
| RUO | |
| Chemical | |
| Antibody | |
| IgG2b |
| ELISA, Immunohistochemistry, Immunoprecipitation, Western Blot | |
| pY20 | |
| HRP | |
| Phosphotyrosine; pTyr; pY | |
| Phosphotyrosine coupled to carrier protein. | |
| 50 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid | |
| Chemical |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu